Gene testing guided individualized oncology medication has landed in outpatient clinics, becoming an important part of precision medicine. By analyzing the genetic characteristics of a patient's tumor, doctors can match the most appropriate targeted drugs for different patients, improving treatment efficacy and reducing ineffective medication.
Testing coverage
Testing covers dozens of druggable genes, including common and rare mutation sites. Reports include evidence levels and medical insurance coverage hints, helping doctors and patients understand the clinical significance of results.
Value of individualized medication
Traditional treatment models often use empirical medication, while gene-guided medication is more precise. Some patients carrying rare mutations can gain access to already marketed new drugs, broadening treatment options.
Treatment process
Overseas patients can first upload pathology and past reports through remote consultation for experts to evaluate testing necessity. After arriving in China, testing and multidisciplinary consultation are completed at partner hospitals.
MedBridge services
MedBridge assists in arranging gene testing and multidisciplinary consultation at partner hospitals, providing report interpretation and follow-up treatment coordination. Costs can be checked through cost estimation.